https://www.premera.com/medicalpolicies/3.01.510.pdf#search=policy
MEDICAL POLICY - 3.01.510 Applied Behavior Analysis (ABA) Effective Date: Jan. 1, 2024 ... below to be directed to that section. POLICY CRITERIA | CODING | RELATED INFORMATION ...
https://www.premera.com/medicalpolicies/5.01.559.pdf#search=policy
PHARMACY / MEDICAL POLICY - 5.01.559 IL-5 Inhibitors Effective Date: Oct. 1, 2023 Last ... POLICY CRITERIA | DOCUMENTATION REQUIREMENTS | CODING RELATED INFORMATION | EVIDENCE ...
https://www.premera.com/medicalpolicies/5.01.562.pdf#search=policy
MEDICAL POLICY - 5.01.562 Imlygic (talimogene laherparepvec) Effective Date: Dec. 1, 2023 ... POLICY CRITERIA | DOCUMENTATION REQUIREMENTS | CODING RELATED INFORMATION | EVIDENCE ...
https://www.premera.com/medicalpolicies/5.01.564.pdf#search=policy
PHARMACY / MEDICAL POLICY - 5.01.564 Pharmacotherapy of Miscellaneous Autoimmune Diseases ... POLICY CRITERIA | DOCUMENTATION REQUIREMENTS | CODING RELATED INFORMATION | EVIDENCE ...
https://www.premera.com/medicalpolicies/5.01.566.pdf#search=policy
PHARMACY / MEDICAL POLICY - 5.01.566 Pharmacotherapy of Thrombocytopenia Effective Date: ... POLICY CRITERIA | DOCUMENTATION REQUIREMENTS | CODING RELATED INFORMATION | EVIDENCE ...
https://www.premera.com/medicalpolicies/5.01.582.pdf#search=policy
MEDICAL POLICY - 5.01.582 Antibody-Drug Conjugates Effective Date: April 1, 2024 Last ... below to be directed to that section. POLICY CRITERIA | CODING | RELATED INFORMATION ...
https://www.premera.com/medicalpolicies/5.01.587.pdf#search=policy
PHARMACY / MEDICAL POLICY - 5.01.587 Hereditary Angioedema Effective Date: May 1, 2023 ... below to be directed to that section. POLICY CRITERIA | DOCUMENTATION REQUIREMENTS | ...
https://www.premera.com/medicalpolicies/5.01.591.pdf#search=policy
MEDICAL POLICY - 5.01.591 Immune Checkpoint Inhibitors Effective Date: May 1, 2024 Last ... POLICY CRITERIA | DOCUMENTATION REQUIREMENTS | CODING RELATED INFORMATION | EVIDENCE ...
https://www.premera.com/medicalpolicies/5.01.595.pdf#search=policy
PHARMACY/MEDICAL POLICY - 5.01.595 Injectable Clostridial Collagenase for Fibroproliferative Disorders BCBSA Ref. Policy: 5.01.19 Effective Date: June 1, 2023 Last Revised: May 5, ...
https://www.premera.com/medicalpolicies/5.01.598.pdf#search=policy
PHARMACY POLICY - 5.01.598 Phosphate Binders Effective Date: April 1, 2024 Last Revised: ... below to be directed to that section. POLICY CRITERIA | DOCUMENTATION REQUIREMENTS | ...
https://www.premera.com/medicalpolicies/5.01.613.pdf#search=policy
PHARMACY POLICY - 5.01.613 Oral Iron Chelating Agents Effective Date: April 1, 2024 Last ... below to be directed to that section. POLICY CRITERIA | DOCUMENTATION REQUIREMENTS | ...
https://www.premera.com/medicalpolicies/7.01.07.pdf#search=policy
MEDICAL POLICY - 7.01.07 Electrical Bone Growth Stimulation of the Appendicular Skeleton BCBSA Ref. Policy: 7.01.07 Effective Date: July 1, 2023 Last Revised: June 12, 2023 ...
https://www.premera.com/medicalpolicies/7.01.137.pdf#search=policy
MEDICAL POLICY - 7.01.137 Magnetic Esophageal Sphincter Augmentation to Treat Gastroesophageal Reflux Disease BCBSA Ref. Policy: 7.01.137 Effective Date: Feb. 1, 2024 Last ...
https://www.premera.com/medicalpolicies/7.01.159.pdf#search=policy
MEDICAL POLICY - 7.01.159 Sphenopalatine Ganglion Block for Headache BCBSA Ref. Policy: 7.01.159 Effective Date: Feb. 1, 2024 Last Revised: Jan. 8, 2024 Replaces: N/A RELATED ...
https://www.premera.com/medicalpolicies/7.01.564.pdf#search=policy
PHARMACY / MEDICAL POLICY - 5.01.564 Pharmacotherapy of Miscellaneous Autoimmune Diseases ... POLICY CRITERIA | DOCUMENTATION REQUIREMENTS | CODING RELATED INFORMATION | EVIDENCE ...
https://www.premera.com/medicalpolicies/7.01.567.pdf#search=policy
MEDICAL POLICY - 7.01.567 Surgical Treatments for Lymphedema and Lipedema BCBSA Ref. Policy: 7.01.162, 7.01.169, 7.01.173 Effective Date: Jan. 1, 2024 Last Revised: Dec. 11, 2023 ...
https://www.premera.com/medicalpolicies/8.01.62.pdf#search=policy
MEDICAL POLICY - 8.01.62 Electronic Brachytherapy for Nonmelanoma Skin Cancer BCBSA Ref. Policy: 8.01.62 Effective Date: Oct. 1, 2023 Last Revised: Sept. 11, 2023 Replaces: N/A ...
https://www.premera.com/medicalpolicies/2.04.509.pdf#search=policy
MEDICAL POLICY - 2.04.509 Cardiovascular Risk Panels BCBSA Ref. Policy: 2.04.65 Effective Date: May 1, 2024 Last Revised: April 9, 2024 Replaces: 2.04.509 RELATED MEDICAL ...
https://www.premera.com/medicalpolicies/2.02.16.pdf#search=policy
MEDICAL POLICY - 2.02.16 Ultrasonographic Measurement of Carotid Intimal-Medial Thickness as an Assessment of Subclinical Atherosclerosis BCBSA Ref. Policy: 2.02.16 Effective Date: ...
https://www.premera.com/medicalpolicies/2.02.18.pdf#search=policy
MEDICAL POLICY - 2.02.18 Progenitor Cell Therapy for the Treatment of Damaged Myocardium Due to Ischemia BCBSA Ref. Policy: 2.02.18 Effective Date: Aug. 1, 2023 Last Revised: July ...